New vaccine to end HIV infections on the way

After a full morning visiting the different locations to inform about HIV and take blood samples, those are analyses in the laboratory of the clinic. The Ndlela (Mpumalanga, South Africa) HIV clinical trial site is a rural clinic for the prevention and testing of hiv and other infections) in the local population. People are informed about the infection, how to prevent it, and are offered to be tested and treated if detected positive.
After a full morning visiting the different locations to inform about HIV and take blood samples, those are analyses in the laboratory of the clinic. PHOTO/GettyImages

The Centers for Disease Control Prevention is working on a HIV vaccine that could see an end to new HIV infections in Kenya.

The vaccine – HPTN-081 – is an antibody-mediated prevention that involves giving antibodies to individuals to protect them from HIV infections.

Speaking during the 40th anniversary of CDC’s partnership with Kenya in Kisumu on Friday, CDC country director Dr Marc Bulterys said research is ongoing to ensure that the vaccine can be widely rolled out.

“We are already done with three trial phases of the vaccine and are working towards making more progress that can help in fully preventing HIV,” Dr Bulterys said.

“We are focusing on women because they are among the groups with high risk of being infected,” he added.

Dr Bulterys also noted that CDC is committed to supporting Universal Health Coverage (UHC) programme in the country.